A well-constructed quality agreement can be an important tool to enable effective collaboration between owner and CMO.
The authors offer insight into cell therapy manufacturing, vector production, and the safety aspects of testing for characterization.
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.
The authors take a look at the past and future impact of the Indian Pharmacopoeia Commission.
Program review can help quality risk management live up to the promise of ICH Q9.
The authors discuss complications of implementing continued process verification and provide recommended approaches.
AAPS supports graduate-level programs impacted by cutbacks in funding and resources.
Selecting a delivery method early on may be beneficial.
The authors developed a test for defects in filter membranes.
Newer classes of biotherapies will require innovations in processing technology.
Switching to single-use bioreactors can have financial and performance benefits.
The industry has made great strides in implementing serialization technologies, while technology developers are enabling more open access to real-time transportation data.
Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.
Switching to single-use bioreactors can have financial and performance benefits.
An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.
The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.
The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.
The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.
The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.
The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.
The author proposes a quality management system that uses the power of executive management to promote a positive quality culture.
The authors re-examine environmental controls in the context of technical advances in manufacturing.
The authors describe an industrialized process for the manufacture of iPSC-derived human cardiomyocytes.
Best practices to strengthen supplier quality management.
A successful QPS acts as a single point of contact for consistent product quality oversight.